Abstracts

ISCT 2021 Abstract Submission Now Open Submission Deadline: February 8th, 2021

Why submit your abstract(s) to ISCT 2021?

  • Global networking: Discuss your research with global leaders in translation science.
  • Publish your work: Accepted abstracts will be published in a special supplement of Cytotherapy, and many studies first presented at ISCT Annual Meetings go on to be published as full-length articles.
  • Present your research: Authors of outstanding abstracts will have the opportunity for LIVE Oral Abstracts, to present their research at the Annual Meeting.
  • Awards: $10,500 award funds to be won at ISCT 2021 New Orleans Virtual:
    • The Top Scoring Abstract Award ($1500 USD)
    • Best Poster Award ($1500 USD)
    • Early Stage Professional Awards ($1000 USD each, 3 available)
    • Technologist Awards ($1000 USD each, 3 available)
    • Top Scoring Musculoskeletal Repair & Regeneration Abstract Award ($1000 USD, 1 available)
    • Top Scoring Emerging Economies Abstract Award ($1,000) – Sponsored by Cytotherapy
    • ESP Rookie of the Year Award ($500 USD) – Sponsored by Cytotherapy

With record breaking attendance, ISCT 2020 Paris Virtual hosted over 2,000 experts from around the world. Abstracts presented at the event were viewed over 17,000 times. Don’t miss this opportunity to maximize the visibility and reach of your work.

Emphasizing the translational focus of ISCT, new abstract subcategories include:

  • Basic Science and Preclinical studies
  • Manufacturing and Regulatory
  • Clinical Investigation

ISCT 2021 Abstract Categories:

  • Mesenchymal Stromal Cells
  • Hematopoietic Stem/Progenitor Cells
  • Immunotherapy
  • Exosomes
  • Embryonic stem cells, iPS and Related
  • Tissue Specific Stem Cells
  • Solid Organ Targeted Therapy
  • Tissue Engineering
  • Gene therapies
  • Process Development and Manufacturing
  • Regulatory Affairs, Quality Systems, Policy, and Ethics

For a complete listing of ISCT 2021 Abstract Categories, click here

General Guidelines:

  • The abstract body cannot exceed 2500 characters, exclusive of the title, author block, images and tables.
  • Abstracts must be submitted via the online Abstract Submission System. Abstracts will NOT be accepted by email, mail, or fax.
  • ISCT may reject abstracts that are considered inappropriate for any reason. Abstracts, once submitted, can only be withdrawn from publication no later than March 22, 2021. If not withdrawn by this deadline, all accepted abstracts will be published in the final program and abstract supplement.
  • Abstract presenters MUST be registered for the meeting. For those requiring acceptance notifications before registering, ISCT 2021 will allow up to two weeks after acceptance for these individuals to register.

Publication:

  • Accepted abstracts will be published in a supplemental version of Cytotherapy, the official journal of ISCT.
  • Abstract presenters MUST be registered for the meeting. For those requiring acceptance notifications before registering, ISCT 2021 will allow up to two weeks after acceptance for these individuals to register.

Fees:

  • There are no fees associated with submitting an abstract. Those presenting abstracts will be responsible for their own travel and meeting expenses.

Embargo* Policy: 

  • Abstracts submitted to the ISCT 2021 Annual Meeting  are embargoed from the time of submission.
  • For the abstract to be eligible for presentation at the ISCT 2021 Annual Meeting, information contained within, as well as additional data and information to be presented about the content, may not be published elsewhere or made public before the abstract has been published/presented at the ISCT 2021 Annual Meeting.
  • Authors must notify ISCT 2021 if, after the submission deadline, the submitted abstract is accepted for publication elsewhere and will be published before the ISCT 2021 Annual Meeting . Publication before the meeting may result in the abstract being removed from the conference.
  • If the Embargo Policy is violated, the abstract may be withdrawn by ISCT 2021 from presentation at the ISCT 2021 Annual Meeting and from publication in the abstract supplement.

*An embargo means that information from any abstract or presentation may not be announced, publicized, or distributed before the embargo date and time.

Notifications:

  • Abstract notifications will be sent to presenters via e-mail by March 10, 2021.
  • Presenters of selected abstracts will be notified whether their abstract has been selected for oral abstract presentation (limited availability) or poster presentation and will need to RSVP by March 22, 2021.

Withdrawal Policy:

  • Requests to withdraw an abstract must come from the presenting author and contact author (if different) on behalf of all listed authors of the abstract. Through the act of submitting the withdrawal request the presenting author and contact author confirm all listed author’s on the abstract are aware and have approved the withdrawal of the abstract in question.
  • Note that abstracts can only be withdrawn from publication until March 22, 2021. After this time, abstracts can be withdrawn from conference participation but will be included in the supplemental publication of Cytotherapy.
  • Requests to withdraw an abstract must be emailed to isct@isctglobal.org.